CalciMedica Common Company Insiders
| CALC Stock | 5.78 0.07 1.23% |
About 93 percent of all CalciMedica Common's insiders are aggressively buying. The analysis of the overall insider sentiment regarding CalciMedica Common Stock suggests that quite a large number of insiders are very bullish. CalciMedica Common employs about 15 people. The company is managed by 15 executives with a total tenure of roughly 35 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive.
Insider Sentiment 93
Aggressively Buying
Selling | Buying |
Latest Trades
| 2025-09-18 | Eric W Roberts | Acquired 2500 @ 3.07 | View | ||
| 2025-09-15 | Eric W Roberts | Acquired 3400 @ 2.68 | View | ||
| 2025-09-12 | Eric W Roberts | Acquired 5000 @ 3.12 | View | ||
| 2025-09-09 | Eric W Roberts | Acquired 2343 @ 3.15 | View | ||
| 2025-08-29 | Eric W Roberts | Acquired 800 @ 2.74 | View | ||
| 2025-08-28 | Eric W Roberts | Acquired 9200 @ 2.86 | View | ||
| 2025-08-21 | Eric W Roberts | Acquired 3508 @ 2.79 | View | ||
| 2025-08-20 | Eric W Roberts | Acquired 2000 @ 2.72 | View | ||
| 2025-08-19 | Sudarshan Hebbar | Acquired 9563 @ 2.82 | View | ||
| 2025-08-15 | Eric W Roberts | Acquired 5076 @ 2.9 | View | ||
| 2025-08-14 | Sudarshan Hebbar | Acquired 1584 @ 2.58 | View | ||
| 2025-07-28 | Kenneth A Stauderman | Acquired 1000 @ 3.96 | View | ||
| 2025-07-25 | Kenneth A Stauderman | Disposed 1000 @ 3.65 | View | ||
| 2025-07-21 | Eric W Roberts | Acquired 1500 @ 3.37 | View | ||
| 2025-07-18 | Robert N Wilson | Acquired 4500 @ 2.87 | View | ||
| 2025-07-14 | A. Rachel Leheny | Acquired 2500 @ 2.47 | View |
Monitoring CalciMedica Common's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
CalciMedica | Build AI portfolio with CalciMedica Stock |
CalciMedica Common Management Team Effectiveness
The company has return on total asset (ROA) of (1.0003) % which means that it has lost $1.0003 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.2636) %, meaning that it created substantial loss on money invested by shareholders. CalciMedica Common's management efficiency ratios could be used to measure how well CalciMedica Common manages its routine affairs as well as how well it operates its assets and liabilities. As of January 7, 2026, Return On Tangible Assets is expected to decline to -0.84. In addition to that, Return On Capital Employed is expected to decline to -1.81. At present, CalciMedica Common's Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 28.5 M, whereas Non Current Assets Total are forecasted to decline to about 110.3 K.The current year's Common Stock Shares Outstanding is expected to grow to about 13.6 M, whereas Net Loss is forecasted to decline to (13.7 M). The market capitalization of CalciMedica Common Stock is USD82.28 Million. Over half of CalciMedica Common's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Shares in Circulation | First Issued 2019-09-30 | Previous Quarter 15 M | Current Value 15 M | Avarage Shares Outstanding 5.8 M | Quarterly Volatility 5 M |
CalciMedica Common Workforce Comparison
CalciMedica Common Stock is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 252. CalciMedica Common holds roughly 15.0 in number of employees claiming about 6% of equities under Health Care industry.
CalciMedica Common Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CalciMedica Common insiders, such as employees or executives, is commonly permitted as long as it does not rely on CalciMedica Common's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, CalciMedica Common insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2025-09-01 | 12.0 | 24 | 2 | 91,866 | 16,000 |
| 2024-09-01 | 16.0 | 16 | 1 | 526,761 | 11,761 |
| 2009-12-01 | 43.0 | 43 | 1 | 800,153 | 0.00 |
| 2006-09-01 | 2.0 | 2 | 1 | 529,992 | 264,996 |
| 2006-03-01 | 1.0 | 1 | 1 | 10,000 | 10,000 |
| 2005-03-01 | 2.5455 | 28 | 11 | 120,118 | 52,800 |
CalciMedica Common Notable Stakeholders
A CalciMedica Common stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as CalciMedica Common often face trade-offs trying to please all of them. CalciMedica Common's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting CalciMedica Common's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Kenneth Stauderman | CoFounder Officer | Profile | |
| Stefan MD | CoFounder Advisor | Profile | |
| Patrick Hogan | CoFounder Advisor | Profile | |
| Anjana Rao | CoFounder Advisor | Profile | |
| Rachel Leheny | CEO Director | Profile | |
| Michael MBA | President COO | Profile | |
| MBA MBA | President COO | Profile | |
| Stephen Bardin | Chief Officer | Profile | |
| Eric Roberts | Chief Board | Profile | |
| Andrew Cunningham | Senior Development | Profile | |
| John JD | General Counsel | Profile | |
| Raven MS | Chief Officer | Profile | |
| Cindy Reiedenberg | Accountant | Profile | |
| Daniel MBA | Interim Officer | Profile | |
| Sudarshan MD | Chief Officer | Profile |
About CalciMedica Common Management Performance
The success or failure of an entity such as CalciMedica Common Stock often depends on how effective the management is. CalciMedica Common management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of CalciMedica management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the CalciMedica management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.80) | (0.84) | |
| Return On Capital Employed | (1.73) | (1.81) | |
| Return On Assets | (0.80) | (0.84) | |
| Return On Equity | (0.86) | (0.90) |
Please note, the presentation of CalciMedica Common's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, CalciMedica Common's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of CalciMedica Common's management manipulating its earnings.
CalciMedica Common Workforce Analysis
Traditionally, organizations such as CalciMedica Common use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare CalciMedica Common within its industry.CalciMedica Common Manpower Efficiency
Return on CalciMedica Common Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 913.3K | |
| Net Loss Per Executive | 913.3K | |
| Working Capital Per Employee | 1.1M | |
| Working Capital Per Executive | 1.1M |
Complementary Tools for CalciMedica Stock analysis
When running CalciMedica Common's price analysis, check to measure CalciMedica Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CalciMedica Common is operating at the current time. Most of CalciMedica Common's value examination focuses on studying past and present price action to predict the probability of CalciMedica Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CalciMedica Common's price. Additionally, you may evaluate how the addition of CalciMedica Common to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |